
Heartseed株式会社
219A | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 港区芝浦1丁目2番3号シーバンスS館5階
- Website:
- https://heartseed.jp/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Heartseed Inc. (株式会社ハートシード) is a pioneering Japanese biotechnology company dedicated to transforming the landscape of regenerative medicine. Focused on tackling the leading cause of death globally—heart disease—Heartseed prioritizes a patient-first approach in developing innovative treatments for refractory conditions. The company's flagship pipeline, HS-001, utilizes iPSC-derived cardiac muscle cells to address heart failure caused by left ventricular dysfunction, offering a groundbreaking method for cardiac repair. Committed to advancing next-generation regenerative therapies, Heartseed actively develops foundational technologies that ensure the safety and efficacy of its solutions. With a team of seasoned experts, Heartseed is positioned at the forefront of cardiac regenerative medicine, aiming to deliver profound impacts on patient lives worldwide.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-06-19 09:00 |
Inside Information Statement
臨時報告書
|
Japanese | 19.9 KB | |
2025-06-12 08:30 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
2025-06-12 08:30 |
Interim Report
半期報告書-第10期(2024/11/01-2025/12/31)
|
Japanese | 143.9 KB | |
2025-01-27 02:01 |
Inside Information Statement
臨時報告書
|
Japanese | 21.3 KB | |
2025-01-27 02:01 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
2025-01-27 02:00 |
Annual Report
有価証券報告書-第9期(2023/11/01-2024/10/31)
|
Japanese | 6.0 MB | |
2025-01-27 02:00 |
Internal Control over Financial Reporting
内部統制報告書-第9期(2023/11/01-2024/10/31)
|
Japanese | 21.1 KB | |
2024-07-22 08:18 |
Regulatory News Service
訂正有価証券届出書(新規公開時)
|
Japanese | 4.6 MB | |
2024-07-11 08:00 |
Regulatory News Service
訂正有価証券届出書(新規公開時)
|
Japanese | 4.6 MB | |
2024-06-26 08:00 |
Prospectus
有価証券届出書(新規公開時)
|
Japanese | 9.0 MB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
Idorsia Ltd | Switzerland | IDIA | |
![]() |
ILIKA PLC | United Kingdom | IGE | |
![]() |
Immuno-Biological Laboratories Co., Ltd. | Japan | 4570 | |
|
Indivior PLC | United Kingdom | INDV | |
![]() |
Infant Bacterial Therapeutics | Sweden | IBT | |
![]() |
Initiator Pharma A/S | Denmark | INIT | |
|
Intercure Ltd. | Israel | INCR | |
![]() |
Intervacc AB | Sweden | IVACC | |
![]() |
Ipsen | France | IPN | |
JCR Pharmaceuticals Co.,Ltd. | Japan | 4552 |